76 related articles for article (PubMed ID: 10612170)
21. Estrogen deficiency and bone loss in women with breast cancer.
Shapiro CL
Breast Cancer Res Treat; 2010 Oct; 123(3):815-8. PubMed ID: 20697804
[No Abstract] [Full Text] [Related]
22. Effect of exogenous conjugated estrogen on plasma gonadotropins and ovarian steroids during the menstrual cycle.
Abraham GE; Chakmakjian ZH; Buster JE; Marshall JR
Obstet Gynecol; 1974 May; 43(5):676-84. PubMed ID: 4362727
[No Abstract] [Full Text] [Related]
23. Female reproductive potential after treatment for Hodgkin's disease.
Horning SJ; Hoppe RT; Kaplan HS; Rosenberg SA
N Engl J Med; 1981 Jun; 304(23):1377-82. PubMed ID: 7231460
[TBL] [Abstract][Full Text] [Related]
24. [Ovariopexy and the treatment of Hodgkin's disease].
Grabenbauer GG; Girke P; Wildt L; Müller RG; Herbst M; Sauer R
Strahlenther Onkol; 1991 May; 167(5):273-6. PubMed ID: 2038709
[TBL] [Abstract][Full Text] [Related]
25. [Lyposomal form of doxorubicin hydrochloride lypodox in the treatment of lymphogranulomatosis and non-Hodgkin's lymphomas].
Ponamareva OV; Kindzel'skiĭ LP; Kulik GI
Lik Sprava; 2001; (1):112-7. PubMed ID: 15311711
[TBL] [Abstract][Full Text] [Related]
26. Ovarian lesions due to cytostatic agents during the treatment of Hodgkin's disease.
Morgenfeld MC; Goldberg V; Parisier H; Bugnard SC; Bur GE
Surg Gynecol Obstet; 1972 May; 134(5):826-8. PubMed ID: 5031498
[No Abstract] [Full Text] [Related]
27. [Some aspects of reproductive function and social adaptation after comprehensive therapy of childhood Hodgkin's disease].
Susuleva NA; Il'iashenko VV
Vopr Onkol; 1997; 43(4):399-402. PubMed ID: 9381688
[TBL] [Abstract][Full Text] [Related]
28. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
[TBL] [Abstract][Full Text] [Related]
29. [The treatment of Hodgkin's disease by taking into account individual sensitivity to antitumor preparations].
Ponomareva OV; Kindzel'skiĭ LP
Lik Sprava; 1997; (1):103-6. PubMed ID: 9221127
[TBL] [Abstract][Full Text] [Related]
30. [Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
Matusewicz W; Drzewoski J; Robak T; Krykowski E
Kardiol Pol; 1983; 26(7):591-4. PubMed ID: 6689036
[No Abstract] [Full Text] [Related]
31. [Evaluation of polychemotherapy and its complications in late stages of Hodgkin's disease].
Anikin BS; Kaganov AL; Tarlova RM
Ter Arkh; 1976; 48(8):73-9. PubMed ID: 1024302
[No Abstract] [Full Text] [Related]
32. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
33. [Management of vomiting induced by polychemotherapy in Hodgkin's disease].
Berényi E; Kiss E
Orv Hetil; 1989 Jun; 130(26):1383-6. PubMed ID: 2748158
[TBL] [Abstract][Full Text] [Related]
34. [Cyclic polychemotherapy of Hodgkin's disease].
Berényi E; Szegedi G
Orv Hetil; 1984 Oct; 125(41):2477-81. PubMed ID: 6493760
[No Abstract] [Full Text] [Related]
35. [Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
Fiacchini M; Lauria F; Mazza P; Tura S
Haematologica; 1982 Jun; 67(3):394-401. PubMed ID: 6814996
[No Abstract] [Full Text] [Related]
36. [Coagulation system in patients with blood malignancies treated with estrogens in the course of cytostatic therapy].
Ignashina EV; Vasil'ev SA; Pivnik AV; Shilin DE; Margolin OV; Kozhurin SV
Ter Arkh; 1998; 70(10):46-8. PubMed ID: 9864804
[TBL] [Abstract][Full Text] [Related]
37. Therapy-related ovarian dysfunction in women treated for Hodgkin's disease.
Morra E; Lazzarino M; Inverardi D; Merante S; Orlandi E; Aprile C; Bernasconi C
Haematologica; 1986; 71(3):209-15. PubMed ID: 3093325
[No Abstract] [Full Text] [Related]
38. [Pregnancy in 4 patients with hypergonadotropinemic amenorrhea].
Peris C; Fessia L; Messineo M; Belforte L; Campagnoli C
Minerva Ginecol; 1981 Jun; 33(6):630-5. PubMed ID: 7279291
[No Abstract] [Full Text] [Related]
39. [Polychemotherapy of generalized forms of Hodgkin's disease].
Koverzneva MM; Kondrat'eva AP; Lorie IuI
Ter Arkh; 1976; 48(8):84-8. PubMed ID: 1024303
[No Abstract] [Full Text] [Related]
40. Prolonged amenorrhea associated with total nodal irradiation for Hodgkin's disease.
Halyard MY; Cornella JL; Grado GL; Rizzo NR
J Natl Med Assoc; 1996 Jun; 88(6):391-3. PubMed ID: 8691503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
